The Valley Desk

NCT00496366 · Interventional trial

Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer

Overall registry status Terminated

Phase 2

Conditions Advanced Breast Cancer, Breast Cancer, HER2/Neu-positive Breast Cancer, Metastatic Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov